About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

A Peter Mac-initiated clinical trial suggests a way to dramatically improve outcomes in patients with high-risk forms of ...

Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...

This update will be presented as part of the OPERA-01 trial-in-progress poster at the American Society ... our OPERA-01 and OPERA-02 pivotal trials with top-line data from OPERA-01 anticipated ...

and cancer screening. For a complete listing of our journal publications and posters, please visit our website.

Studies doing genome-wide testing can easily ID patients with naturally low neutrophil counts, but nobody's looking at it, ...

Living in food deserts, clinical trial deserts, and areas with high transportation vulnerability significantly lowers breast ...

Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not ...

Title: Phase 1 clinical trial of autologous T-cells genetically ... in recurrent ovarian cancer (OVCA) Session Type: E-Poster Poster No.: 145eTiP About Anixa Biosciences, Inc. Statements that ...